Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (291-300 of 759) with videos related to

Pageof 76
Sort By:
Cardiology and Therapy|December 20, 2023
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes SurveyJuan González-Moreno, Angela Dispenzieri, Martha Grogan, et al.
Blood Cancer Journal|July 8, 2018
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trialsSikander Ailawadhi, Susanna Jacobus, Rachael Sexton, et al.
Contemporary Clinical Trials Communications|August 5, 2022
A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncologyRahma Warsame, Joselle Cook, Briant Fruth, et al.
Mayo Clinic Proceedings|July 5, 2021
Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac AmyloidosisMartha Grogan, Francisco Lopez-Jimenez, Michal Cohen-Shelly, et al.
World Journal of Transplantation|July 1, 2016
Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experienceMartha Grogan, Morie Gertz, Arleigh McCurdy, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|June 29, 2007
Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiographyDiego Bellavia, Theodore P Abraham, Patricia A Pellikka, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 12, 2013
Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratificationLuciano J Costa, Elizabeth J Nista, Francis K Buadi, et al.
Blood|May 25, 2010
Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complicationsGiada Bianchi, Robert A Kyle, Colin L Colby, et al.
American Journal of Nephrology|April 5, 2012
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantationHarris V K Naina, Samar Harris, Angela Dispenzieri, et al.
Haematologica|July 24, 2025
Proteomic shifts post plasma cell therapy in AL amyloid plaques and potential implications for light chain directed anti-fibril monoclonal antibodiesMatthew J Rees, Surendra Dasari, Ellen D McPhail, et al.
Pageof 76

Showing results (291-300 of 759) with videos related to

Sort By:
Pageof 76
Cardiology and Therapy|December 20, 2023
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes SurveyJuan González-Moreno, Angela Dispenzieri, Martha Grogan, et al.
Blood Cancer Journal|July 8, 2018
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trialsSikander Ailawadhi, Susanna Jacobus, Rachael Sexton, et al.
Contemporary Clinical Trials Communications|August 5, 2022
A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncologyRahma Warsame, Joselle Cook, Briant Fruth, et al.
Mayo Clinic Proceedings|July 5, 2021
Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac AmyloidosisMartha Grogan, Francisco Lopez-Jimenez, Michal Cohen-Shelly, et al.
World Journal of Transplantation|July 1, 2016
Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experienceMartha Grogan, Morie Gertz, Arleigh McCurdy, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|June 29, 2007
Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiographyDiego Bellavia, Theodore P Abraham, Patricia A Pellikka, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 12, 2013
Prediction of poor mobilization of autologous CD34+ cells with growth factor in multiple myeloma patients: implications for risk-stratificationLuciano J Costa, Elizabeth J Nista, Francis K Buadi, et al.
Blood|May 25, 2010
Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complicationsGiada Bianchi, Robert A Kyle, Colin L Colby, et al.
American Journal of Nephrology|April 5, 2012
Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantationHarris V K Naina, Samar Harris, Angela Dispenzieri, et al.
Haematologica|July 24, 2025
Proteomic shifts post plasma cell therapy in AL amyloid plaques and potential implications for light chain directed anti-fibril monoclonal antibodiesMatthew J Rees, Surendra Dasari, Ellen D McPhail, et al.
Pageof 76